chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within few minutes, I started feeling high heart rate and dizzy. Notified health care professional and they took me in to observe vitals. Heart rate and blood pressure was higher than normal. EKG looked normal but with higher heart rate. Started feeling better in an hour and went home. The high heart rate recurred the next several days but would go away after few minutes.  Occasionally I get a headache and feel resting heart rate is higher than before. Definitely feeling better after two weeks compared to day of the shot.
Seizure occurred during sleep; lasted approx. 2 minutes; checked out at ER; CT scan showed no bleeds/infection. There was no fever prior to or following seizure. Followed up with Dr. same day.
No adverse event - Moderna monovalent given.   Client contacted and explained Moderna Bivalent available and can return to health department in two months from last dose and receive Moderna Bivalent that covers variant of Covid.   Client voiced understanding.
Kinrix given as 4th DTaP dose; Kinrix given to a 12-year-old; 2nd DTaP on 13Apr2010, 3rd on 01May2010 as Pediarix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number H99J7, expiry date 26-MAY-2023) for prophylaxis.   Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis.   Previously administered products included Boostrix (An year ago on an unknown date, received a dose). Concomitant products included DIPHTHERIA VACCINE TOXOID + PERTUSSIS VACCINE ACELLULAR + TETANUS VACCINE TOXOID (DTAP VACCINE).   On 04-NOV-2022, the patient received Kinrix. On 01-MAY-2010, the patient received Pediarix. On 01-MAY-2010, not applicable after receiving Kinrix and an unknown time after receiving Pediarix, the patient experienced drug dose administration interval too short (Verbatim: 2nd DTaP on 13Apr2010, 3rd on 01May2010 as Pediarix). On 04-NOV-2022, the patient experienced inappropriate schedule of vaccine administered (Verbatim: Kinrix given as 4th DTaP dose) and inappropriate age at vaccine administration (Verbatim: Kinrix given to a 12-year-old). The outcome of the drug dose administration interval too short, inappropriate schedule of vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 07-MAR-2023 A medical assistant supervisor reported that since there was an issue with the dose not being valid a 4th dose of Kinrix was given at 12 years. The patient received his 2nd and 3rd dose of DTaP as Pediarix. A year ago, patient had received Boostrix. The reporter consented to follow up. Since the patient received Kinrix as 4th dose of DTap vaccine at age 12 years, which led to inappropriate schedule of vaccine administered and inappropriate age at vaccine administration. The patient received the 3rd dose of DTap (Pediarix) earlier than the recommended schedule, which led to shortening of vaccine schedule.
Bleeding at injection site, bruise the size of quarter with rash developing after a day down the arm the size of a playing card.
Red inflamed circle around injection site, warm to the touch; started about 36 hours after booster shot
Full body rash and hives, incredibly itchy. Bottom lip swelled up. Had to go to urgent care. Received steroid and benadryl shot. Got a steroid prescription.. Rash came back at 2am. Went to Dr's office. They recommended taking zyrtec and peocid ac every morning and night. Rash keeps coming back in different locations. Dr is performing bloodwork. My second vaccine is appt is 04.10 need to know if I should still go or reschedule.  I've never had an allergic reaction, rash or hives before.
Information has been received from a registered nurse concerning a female who was vaccinated with a dose of varicella vaccine. The pt developed an 8-10 lesion rash. It was reported that "the capsules appeared to have stria within them." It was reported to be unknown if the pt sought medical attention. Additional info has been requested.
Developed fever of 101.3 at it's highest (yesterday evening). Accompanied by sweats (soaked through clothes/bed sheets), chills/trembles, fatigue, general aches and weakness,  acute soreness at the muscle. Following morning woke up still with 100F temp, last took tylenol at 8am, fever has since remained down/normal (it is now 3pm). Still with some sweats/feeling hot, though temp is staying normal.
Information has been received from a other health professional concerning a patient of unspecified age and gender. It was reported that on 17OCT0214 a patients was vaccinated with an expired dose of VARIVAX (Merck). No adverse events were reported. The outcome of the event was unknown. Additional information is expected.
Swelling of the lymph node in left axilla; This is a spontaneous report from a contactable nurse (patient). A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection Batch/Lot number:EK4176 Exp Date: not reported), via an unspecified route of administration on an unspecified date (at the age of  43-year-old) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. It was also reported that prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced swelling of the lymph node in left axilla on 27Jan2021. The patient has not been tested for COVID-19 since vaccination. The outcome of the event was not recovered.
Patient complained of her right shoulder aching on 06/22/2001 and her left should aching on 06/23/2001. Patient also complained of her hip aching. Dr does not think these symptoms are vaccine related. Blood work was done, but there are no results yet.
Patient complaint of rash to arms and legs starting after receiving vaccination on 6/16/21.  Patient seen at ER on 6/18/21.  Labs unremarkable and treated with oral Benadryl, oral Pepcid, and oral Motrin.  He was sent home with prescription for Benadryl and Pepcid and to f/u with PCP.  He was seen by provider 6/22/21 and was given Triamcinolone Injection & order for Hydroxyzine for continued itching.  Patient reported at that time that he thinks he has bed bugs and unsure if rash from that or vaccine.  Seen on 6/28/21 seen again for rash on abdomen and forearms, started on Prednisone and Triamcinolone Acetonide Cream.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021 at 10:03 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 21-Mar-2021 at 11:41 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 14-Feb-2021 at 10:03 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 38.65 Years.   Concomitant products were not provided.   On 14-Feb-2021, Excursion time was 09:00 AM, temperature was 32,  10:00 AM, temperature was 32, 11:00 AM, temperature was 32, 02:00 PM, temperature was 35, 03:00 PM, temperature was 35, total doses given for the day was 162, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021. On 21-Mar-2021, Excursion time was 09:00 AM, temperature was 34,  10:00 AM, temperature was 32, 11:00 AM, temperature was 34, total doses given for the day was 94, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 16-Mar-2021, vial was moved to clinic on 21-Mar-2021. 10 vials were sent to clinic. Vaccine BUD date was 15-Apr-2021.   The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.   Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.   After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.   It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.   Treatment medications were not reported.
Hotness, swelling and bruising at the injection site, lasted for 5 days. Treated with benadryl and zyrtec
itching the same day; rash/ red lines on the inside of her arm that run perpendicular to her arm; Tender; sore arm; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching the same day), RASH ERYTHEMATOUS (rash/ red lines on the inside of her arm that run perpendicular to her arm), TENDERNESS (Tender), PAIN IN EXTREMITY (sore arm) and RASH (Rash) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Acid reflux (esophageal) and Thyroid disorder. Concomitant products included LANSOPRAZOLE (PREVACID) for Acid reflux (esophageal), LOSARTAN POTASSIUM (LOSARTIN) and HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for Blood pressure high, LEVOTHYROXINE for Thyroid disorder.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PRURITUS (itching the same day), RASH ERYTHEMATOUS (rash/ red lines on the inside of her arm that run perpendicular to her arm), TENDERNESS (Tender), PAIN IN EXTREMITY (sore arm) and RASH (Rash). On 29-May-2021, PRURITUS (itching the same day), RASH ERYTHEMATOUS (rash/ red lines on the inside of her arm that run perpendicular to her arm), TENDERNESS (Tender), PAIN IN EXTREMITY (sore arm) and RASH (Rash) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, Body temperature: 97.3 (normal) 97.3 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication include Anti itch cream.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Reporter's address and email address, Patient's demographic details, Patient's other relevant history, Lab data, Concomitant medications, 2nd dose start date, New event rash with outcome of all events, Causality of events were added.
On 08/09/2000, the patient developed 5-6 lesions on his anterior left forearm, only 1 of which was vesicular. The lesions were raised and resemble mosquito bites. Subsequently, the patient recovered. The reporter stated a concern about the lot. Five additonal patients had similar experienced following exposure to varicella virus vaccine live. Unspecified medical attention was sought. Additional information has been requested.
Patient had lightheadedness, nausea, vomiting and diarrhea for 24h after injection, numbness in hands and feet and rapid heartbeat.
1st shot: Same day: aches and fogginess for 24 hours  2nd shot: Same day: aches, fogginess, fatigue, and growing SOB, heaviness and tightness in chest, frighteningly forceful occasional heart beat, irregular heart rhythm over the next couple of weeks. Aches gone in 24 hours. Fogginess, fatigue. SOB, chest and heart symptoms significantly subsided 19 days after 2nd shot.
Red all around arm, swayed when standing up, painful when lifting arm, some swelling around arm, sick for a week. Benadryl for pain.
Pregnant and received both the doses of vaccine; Fatigue which left for around 8 hours; body ache; This spontaneous prospective pregnancy case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant and received both the doses of vaccine), FATIGUE (Fatigue which left for around 8 hours) and MYALGIA (body ache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Sinus tachycardia in 2015, Polycystic ovarian syndrome in 2015, Obesity in 2015 and Vitamin D deficiency in 2015. Family history included Hypertension since an unknown date, Hypertension (Father's history), Diabetes (Father and Mother's History), Hyperlipidemia (Father's History), Gout (Father's History) and Hashimoto's disease (Mother's History). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE], METFORMIN, METOPROLOL and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 16-Dec-2020 and the estimated date of delivery was 29-Sep-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant and received both the doses of vaccine), FATIGUE (Fatigue which left for around 8 hours) and MYALGIA (body ache). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant and received both the doses of vaccine) had resolved and FATIGUE (Fatigue which left for around 8 hours) and MYALGIA (body ache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant Product also includes: Prenatal Fish Oil  Action taken with mRNA-1273 in response to the event was not applicable.
Dose number:3; Armpit is extremely swollen even 4 days after shot; This is a spontaneous report from a non-contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 25-year-old male patient received bnt162b2 (BNT162B2), administration date 11Dec2021 (Lot number: FJ8762) at the age of 25 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: ER8730; Route of administration: Unspecified), for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot Number: EW0164; Route of administration: Unspecified), for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 11Dec2021, outcome "unknown", described as "Dose number:3"; SWELLING (non-serious) with onset an unknown date in Dec2021, outcome "not recovered", described as "Armpit is extremely swollen even 4 days after shot".  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
I took the Moderna Vaccination on August 26, 2021 (afternoon hours) at my local Pharmacy given to me by the Pharmacist in town location indicated above. On September 18th 2021 I experienced numbness in my lower extremities and left fingers
localized erythema, edema, pain started about 2 days after vaccination. Seen on 8/11, reports symptoms getting better
This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms), HYPERSOMNIA (slept for up to 23 hours), PAIN IN EXTREMITY (Pressure in the legs and hips), PYREXIA (Fever (101F)) and NAUSEA (Nausea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HCTZ), AMLODIPINE, CLOPIDOGREL BISULFATE (PLAVIX) and EZETIMIBE for an unknown indication. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced INFLUENZA (Flu symptoms), HYPERSOMNIA (slept for up to 23 hours), PAIN IN EXTREMITY (Pressure in the legs and hips), PYREXIA (Fever (101F)), NAUSEA (Nausea), ARTHRALGIA (Generalized sore and achy joints), HEADACHE (Severe Headaches) and INJECTION SITE PAIN (Tenderness at injection site). On 19-Apr-2021, INFLUENZA (Flu symptoms), PAIN IN EXTREMITY (Pressure in the legs and hips), PYREXIA (Fever (101F)), NAUSEA (Nausea), ARTHRALGIA (Generalized sore and achy joints) and HEADACHE (Severe Headaches) had resolved. At the time of the report, HYPERSOMNIA (slept for up to 23 hours) and INJECTION SITE PAIN (Tenderness at injection site) outcome was unknown.
Received my 2nd dose approx. 10:15am on 3/29/2021. Felt fine throughout the day, tried to stay busy & moving  to allow vaccine to disperse.  Watched TV that evening & noticed around 10pm that the shot site was beginning to ache & also felt a bit achy thru back & shoulders. By the time I went to bed around 11:30 I was having extreme freezing chills & muscle aches all over.  I took a Tylenol before going to bed. Woke up at 2:30am & again at 4:30am due to extreme muscle pain from head to toe & still having freezing chills. Got up around 7am, still feeling achy but not chilling as much, however, felt slight nausea & weakness as though I was going to pass out. Sat down for a few minutes until I felt better. Throughout all day Tuesday March 30, the muscle aches abated but I continued to feel drained & had a constant headache. I took Tylenol to ease the aches.
pt recv vax & exp vaccine failure;pt has chickenpox disease 20mo p/vax;
This study case was received from the investigator in a trial on 04 January 2013. A female subject (age and date of birth not reported) had received the following vaccinations on 18 July 2012: ACAM2000 (lot number, site and route not reported) and anthrax vaccine (manufacturer, lot number, route and site not reported). Two days post-vaccination on 20 July 2012, the subject experienced chest pain. The subject had no reported medical history. The subject's outcome was unknown. Documents held by sender: None.
Information has been received from a physician concerning an 11 year old female who was vaccinated on an unspecified date with her first dose of GARDASIL vaccine (yeast) (lot# not reported). Subsequently the patient experienced prolonged vomiting. The patient sought medical attention by seeing the physician on an unspecified date. The patient's outcome was not reported. Additional information has been requested.
Noted 2" diameter, slightly elevated, red, irregular skin area where injection given.  Denies itching or pain.  Instructed to notify primary physician.
Narrative:  The patient received three doses of COVID 19 Vaccine (two doses Moderna Jan/Feb 2021 and one dose Moderna Nov 2021). The patient tested positive on 12 Jan 2022. The patient presented to the ED with weakness, nausea, and not eating. The patient was admitted with covid hyponatremia and acute kidney failure. The patient was discharged in stable condition on 25 Jan 2022.
presented to ED with SOB; c/o cough, flu like sx, SOB, weakness, head congestion and runny nose x 2-3 wks; started using wife's O2 at home due to SOB; chest xray showed bilateral infiltrates; positive COVID test; acute respiratory failure due to COVID; pt passed away in the hospital
Living with CLL, diagnosed in July 2014, (2) prior rounds of treatment.  A recurrence led to plans for additional treatment, but the only action as of the Covid vaccine date was a prior month of Allopurinal as prophylactic for TLS.  On 6/10, I had an inguinal hernia repair in an outpatient surgery center.  I had noted some pain in the kidney area for a couple of weeks prior, and the medical staff performed a pre-surgical urinalysis to diagnose a potential UTI, which was negative.  The day following my 2nd Moderna injection (6/15) I awoke with mild headache, nausea, and fatigue which lasted for approximately (4) days.    Fast forward to 6/24 (10 days after the vaccination), I appeared to relapse with similar symptoms.  The fatigue and subsequent onset of fever was debilitating. I stopped eating and got weaker and mentally incoherent.  I was taken to the ER on 6/28, and admitted for about (4) days total.  I had a 103F fever, and blood tests showed kidney failure levels of uric acid, etc.  They also showed that my already elevated WBC was spiking.  I was put on IV antibiotic (cephalexin analog I believe), constant hydration, and heparin injections.    After three days the fever resolved.  The Infectious Disease Team was unable to identify any causative organism in the blood culture.  I was released to the care of my Oncologist, who scheduled me for infusions of 2 L. daily hydration for two weeks.  After completion of that regimen, my kidney chemistry was back to normal ranges and I was able to resume regular activities including gym workouts.  Prior to all of this, CLL blood monitoring had tracked my WBC to around 86K, leading to the plan to enter treatment.  While I was hospitalized, they took daily blood draws which showed a large upswing in WBC to roughly 162K.  By the time I was released the WBC was on its way back down to pre-event levels.  Since that time, I have begun the new CLL regimen of Calquence (acalabrutinib), an orally administered kinase inhibitor.  The WBC at the most recent draw was in the low 30K's.  No one has drawn a clear connection between my experiences and the Covid vaccination unless the affect on eating and drinking led to extreme dehydration.  I've previously had CLL/WBC numbers much higher than this with no outward symptoms beyond swollen lymph nodes and splenomegaly.  One of my nurses, during the recent hospitalization, simply suggested that I submit this report due to the odd sequence of events.
Patient noted that her left arm started to get red and hot last night, but really noticed it this morning. Outside of left arm is red, hot, and swollen. NOT accompanied by fever, and the surface of the skin does not look puckered.  Patient has used ice pack to arm with some relief and just took aspirin ~1 hour ago to assist with inflammation. Patient noted this reaction was DIFFERENT than her reaction to the tetanus vaccine, she repeats NO BREATHING ISSUES with this flu shot. Patient informed VAERS would be submitted and PCP immediately notified.